share_log

Morgan Stanley Initiates Coverage On ProKidney With Equal-Weight Rating, Announces Price Target of $13

Benzinga Real-time News ·  Nov 10, 2022 08:02

Morgan Stanley analyst Vikram Purohit initiates coverage on ProKidney (NASDAQ:PROK) with a Equal-Weight rating and announces Price Target of $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment